What is IRAM 2063/1982?

IRAM 2063/1982, also known as the International Register of Antimicrobial Chemotherapeutic Agents in Medicine, is a comprehensive list of therapeutic agents used to treat various infectious diseases. It was first published in 1982 by the International Society of Chemotherapy (ISC). This register serves as a valuable resource for healthcare professionals, researchers, and regulatory agencies in ensuring the safe and effective use of antimicrobial drugs.

The Purpose of IRAM 2063/1982

The primary objective of IRAM 2063/1982 is to provide a standardized classification system for antimicrobial drugs based on their chemical structure, mechanism of action, and spectrum of activity against different microorganisms. This classification helps healthcare professionals in choosing the most appropriate treatment option for specific infections, considering factors such as drug resistance patterns, potential side effects, and patient characteristics. The register also assists regulatory agencies in monitoring and regulating the use of antimicrobial drugs to prevent misuse and promote public health.

The Importance of IRAM 2063/1982

IRAM 2063/1982 plays a crucial role in combating the global threat of antimicrobial resistance. By providing information on the effectiveness and safety of different antimicrobial agents, the register helps healthcare providers make informed decisions about prescribing antibiotics and other antimicrobial drugs. It also facilitates research efforts in developing new drugs and treatment strategies, taking into account the existing knowledge and gaps in the field of antimicrobial therapy. Moreover, IRAM 2063/1982 fosters international collaboration and communication among scientists, clinicians, and policymakers in tackling antimicrobial resistance on a global scale.

Further Developments and Updates

Since its initial publication, IRAM 2063/1982 has undergone several revisions and updates to incorporate new drugs, emerging resistance patterns, and changes in clinical guidelines. These updates are essential to ensure that the register remains relevant and up-to-date in the face of evolving infectious diseases and antimicrobial resistance challenges. The ISC and other relevant organizations continually work together to gather data, conduct research, and review existing evidence to provide accurate and timely information for the global healthcare community.